<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03863951</url>
  </required_header>
  <id_info>
    <org_study_id>XJTU1AF-CRF-2018-024</org_study_id>
    <nct_id>NCT03863951</nct_id>
  </id_info>
  <brief_title>Poststroke Depression of Clinical Trial Registration</brief_title>
  <acronym>IFEPSDAIS</acronym>
  <official_title>The Study on the Association of Intestinal Flora and Early Post-stroke Depression in Patients With Acute Ischemic Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>First Affiliated Hospital Xi'an Jiaotong University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>First Affiliated Hospital Xi'an Jiaotong University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators aim to explore the relationship between gut microbiota composition and&#xD;
      earlier poststroke depression via 16S rRNA sequencing.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study, patients with first ever acute ischemic stroke were studied. According to the&#xD;
      psychological assessment, patients were divided into two groups according to whether or not&#xD;
      there was a PSD at the earlier stage of stroke. Clinical biological data and blood and feces&#xD;
      samples were collected. Firstly, 16srDNA sequencing was used to study the difference in the&#xD;
      composition and diversity of intestinal microbial communities in the two groups of patients.&#xD;
      Then the two groups selected individual representative samples and conducted macro genome&#xD;
      sequencing. At the same time, by analyzing the correlation between the intestinal flora and&#xD;
      the clinical risk factors and neurotransmitters in early PSD patients, the key functional&#xD;
      bacteria related to PSD were identified.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">January 20, 2019</start_date>
  <completion_date type="Anticipated">February 28, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Months</target_duration>
  <primary_outcome>
    <measure>The Composition of Intestinal Microbial Communities Calculated by OTU Analysis</measure>
    <time_frame>2 weeks</time_frame>
    <description>The composition were measured in number based on OTU data</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The Diversity of Intestinal Microbial Communities Calculated by OTU Analysis</measure>
    <time_frame>2 weeks</time_frame>
    <description>Community diversity measured in the Shannon index</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The Poststroke Depression Assessed by Hamilton Rating Scale for Depression (HAMD-17) Score</measure>
    <time_frame>3 months</time_frame>
    <description>Mild depression（HAMD-17 Score&gt;7，≤17）, moderate depression（HAMD-17 Score&gt;17，≤24）, major depression（HAMD-17 Score&gt;24）</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Functional Independence Assessed by Modified Rankin Scale (mRS）score</measure>
    <time_frame>3 months</time_frame>
    <description>MRS score range from 0 to 6. Favourable outcome (mRS score≤2), worse outcome (mRS score&gt;2), and death (mRS score = 6).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The Plasma Level of 5-Hydroxytryptamine( 5-HT) Neurotransmitter Using Enzyme-Linked Immunosorbent Assay ( ELISA) Methods</measure>
    <time_frame>2 weeks</time_frame>
    <description>5-HT measured in mmol/L</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Stroke</condition>
  <condition>Depression</condition>
  <arm_group>
    <arm_group_label>Patients with poststroke depression</arm_group_label>
    <description>No intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients without poststroke depression</arm_group_label>
    <description>No intervention</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        acute ischemic stroke patients&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  diagnosed with the first ever acute ischemic stroke occurring within 2 weeks and were&#xD;
             confirmed by CT or MRI,&#xD;
&#xD;
          -  has no history of depression or use of antidepressants or antipsychotics,&#xD;
&#xD;
          -  were competent to consent to take part in this research.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  significant acute or severe illness such as infection,heart failure and tumor,&#xD;
&#xD;
          -  previous diagnosis of depression or other mental disorder or who had recently accepted&#xD;
             antidepressants or antipsychotics,&#xD;
&#xD;
          -  antibiotics in the last two weeks,&#xD;
&#xD;
          -  severe aphasia or dysarthria,irritable bowel syndrome,asthma,and pregnant or lactating&#xD;
             women,&#xD;
&#xD;
          -  a previous history of neurological illness including AD and PD，&#xD;
&#xD;
          -  Inflammatory bowel disease，&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Yurong Zhang, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>First Affiliated Hospital Xi'an Jiaotong University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yurong Zhang, PhD</last_name>
    <phone>0086-029-85323443</phone>
    <email>zhangyurong72@mail.xjtu.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Yurong Zhang</name>
      <address>
        <city>Xi'an</city>
        <state>Shaanxi</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yurong Zhang</last_name>
      <email>zhangyurong72@mail.xjtu.edu.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>February 24, 2019</study_first_submitted>
  <study_first_submitted_qc>March 4, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 5, 2019</study_first_posted>
  <last_update_submitted>March 4, 2019</last_update_submitted>
  <last_update_submitted_qc>March 4, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ischemic stroke</keyword>
  <keyword>depression</keyword>
  <keyword>intestinal microbiota</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

